United Therapeutics (UTHR) Tops Q3 EPS by 194c
Tweet
Share
E-mailGet Alerts UTHR Hot Sheet
Price: $513.12 -1.51%
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Net income per basic common share (in dollars per share): 3.75
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
United Therapeutics (NASDAQ: UTHR) reported Q3 EPS of $3.91, $1.94 better than the analyst estimate of $1.97. Revenue for the quarter came in at $330 million versus the consensus estimate of $335.1 million.
For earnings history and earnings-related data on United Therapeutics (UTHR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- Is the global equity rally broadening? UBS weighs in
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
